当前位置:首页 - 行情中心 - 康众医疗(688607) - 财务分析 - 现金流量表

康众医疗

(688607)

  

流通市值:26.52亿  总市值:26.52亿
流通股本:8812.90万   总股本:8812.90万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金235,619,980.16148,230,647.8269,670,228.34297,606,501.06
  收到的税费返还10,824,485.165,545,942.831,936,494.3610,279,829.83
  收到其他与经营活动有关的现金6,549,275.866,576,173.451,047,415.639,767,038.34
  经营活动现金流入小计252,993,741.18160,352,764.172,654,138.33317,653,369.23
  购买商品、接受劳务支付的现金218,098,992.12131,496,317.1961,719,676.18167,825,717.37
  支付给职工以及为职工支付的现金63,833,440.7344,757,651.8324,234,018.7780,708,000.98
  支付的各项税费10,323,493.25,218,509.535,888,325.349,712,154.44
  支付其他与经营活动有关的现金34,339,024.328,235,390.715,446,750.636,787,796.44
  经营活动现金流出小计326,594,950.35209,707,869.25107,288,770.89295,033,669.23
  经营活动产生的现金流量净额-73,601,209.17-49,355,105.15-34,634,632.5622,619,700
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,393,788.882,851,736.11148,209.711,226,750.28
  处置固定资产、无形资产和其他长期资产收回的现金净额133,122.56133,657.17-33,588.2
  收到的其他与投资活动有关的现金1,314,124,5001,048,510,000517,515,6001,684,502,150
  投资活动现金流入小计1,318,651,411.441,051,495,393.28517,663,809.71,695,762,488.48
  购建固定资产、无形资产和其他长期资产支付的现金28,442,129.3625,706,424.919,434,577.8696,204,755.46
  投资支付的现金30,000,00020,000,000-119,080,455.66
  支付其他与投资活动有关的现金1,299,768,100991,419,600494,554,8001,497,878,950
  投资活动现金流出小计1,358,210,229.361,037,126,024.91503,989,377.861,713,164,161.12
  投资活动产生的现金流量净额-39,558,817.9214,369,368.3713,674,431.84-17,401,672.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金310,456.25309,725.99303,718.052,311,972.5
  取得借款收到的现金50,000,00020,000,000-5,311,566.45
  筹资活动现金流入小计50,310,456.2520,309,725.99303,718.057,623,538.95
  偿还债务支付的现金17,585,236.862,585,236.862,585,236.8610,843,547.13
  分配股利、利润或偿付利息支付的现金5,330,870.245,370,197.09-5,018,959.54
  支付其他与筹资活动有关的现金3,536,067.29966,786.8-15,444,143.49
  筹资活动现金流出小计26,452,174.398,922,220.752,585,236.8631,306,650.16
  筹资活动产生的现金流量净额23,858,281.8611,387,505.24-2,281,518.81-23,683,111.21
四、汇率变动对现金及现金等价物的影响-721,823.52893,930.63472,456.55-1,801,903.66
五、现金及现金等价物净增加额-90,023,568.75-22,704,300.91-22,769,262.98-20,266,987.51
  加:期初现金及现金等价物余额221,907,862.48221,907,862.48221,907,862.48242,174,849.99
  期末现金及现金等价物余额131,884,293.73199,203,561.57199,138,599.5221,907,862.48
补充资料:
  净利润--678,824.81-17,675,708.03
  资产减值准备--85,757.17-5,329,912.79
  固定资产和投资性房地产折旧-1,406,680.69-2,500,439.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,406,680.69-2,500,439.45
  无形资产摊销-167,221.6-400,883.18
  长期待摊费用摊销-1,594,478.96-2,882,168.11
  处置固定资产、无形资产和其他长期资产的损失--5,515.14-3,175.66
  固定资产报废损失-121,271.72--
  公允价值变动损失-313,217-1,146,507.39
  财务费用-215,346.93-2,207,492.65
  投资损失--821,072.79--6,535,540.82
  递延所得税--2,194,235.79--453,018.79
  其中:递延所得税资产减少--1,916,512.58--334,907.03
    递延所得税负债增加--277,723.21--118,111.76
  存货的减少--41,712,051.17-5,011,978
  经营性应收项目的减少--19,424,654.12--29,339,454.18
  经营性应付项目的增加-433,551.83-14,957,687.67
  其他-420,035.85-556,320
  现金的期末余额-199,203,561.57-221,907,862.48
  减:现金的期初余额-221,907,862.48-242,174,849.99
  现金及现金等价物的净增加额--22,704,300.91--20,266,987.51
公告日期2025-10-232025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑